Riesgo vascular en enfermedades endocrinológicas distintas a la diabetes

  1. Isabel Antequera 1
  2. José I. Cuende 2
  3. Jerónimo Nieto López-Guerrero 3
  1. 1 Hospital Universitario Virgen de la Victoria
    info
    Hospital Universitario Virgen de la Victoria

    Málaga, España

    ROR https://ror.org/05xxs2z38

    Geographic location of the organization Hospital Universitario Virgen de la Victoria
  2. 2 Complejo Asistencial Universitario de Palencia
    info
    Complejo Asistencial Universitario de Palencia

    Palencia, España

    ROR https://ror.org/02atpex25

    Geographic location of the organization Complejo Asistencial Universitario de Palencia
  3. 3 Servicio de Medicina Interna, Hospital de Cantoblanco, Madrid
Journal:
Clínica e investigación en arteriosclerosis

ISSN: 0214-9168 1578-1879

Year of publication: 2016

Volume: 28

Issue: 4

Pages: 197-201

Type: Article

DOI: 10.1016/J.ARTERI.2015.05.001 DIALNET GOOGLE SCHOLAR

More publications in: Clínica e investigación en arteriosclerosis

Sustainable development goals

Abstract

Endocrinological diseases directly affect the cardiovascular system. The deleterious effects on cardiovascular function can be direct, and linked to the increase or reduction of circulating hormones. Equally, the adverse effects may be indirect; for example following the rise in blood pressure, increase or redistribution of lean mass, or increased plasma lipoproteins. The best health care and the increasing availability of biochemical tests lead to the diagnosis of many endocrine diseases before the onset of clinical signs. This review will focus on presenting evidence of cardiovascular functional or structural impairment in cases of primary hyperparathyroidism, Cushing's syndrome, and hypothyroidism in their sub-clinical forms, as well as the reversibility of complications after appropriate treatment.